1.30 Indemnitee and Indemnitor have the respective meanings set forth in Section 11.3.
1.31 IP means intellectual property.
1.32 Joint Inventions means inventions and intellectual property rights therein made jointly by or on behalf of employees, agents or consultants of Licensee and Licensor.
1.33 Know-How means any proprietary technical or other information whether patentable or not and whether in written or verbal form, which is confidential and may include technology, experience, formulae, concepts, discoveries, trade secrets, inventions, modifications, improvements, data (including all chemical, biological, preclinical, pharmacological, clinical, pharmacokinetic, toxicological, analytical and quality control data), results, designs, ideas, analyses, methods, techniques, assays, research plans, procedures, tests, processes (including manufacturing processes, specifications and techniques), laboratory records, reports, summaries, and information contained in submissions to, and information from, regulatory authorities.
1.34 Licensee Improvements means Improvements that relate specifically to Licensee Technology (other than inventions that relate specifically to Licensor Technology) developed, conceived, reduced to practice, or invented, and intellectual property rights therein, made by or on behalf of employees, agents or consultants of Licensee or Licensor, or Joint Inventions, and that relate to Antibody structure, Antibody formulation, methods of using Antibodies, processes for manufacturing Antibodies (other than inventions directed to the generation or application of Licensor Technology) and/or inventions made by Licensee or Joint Inventions incorporating any of the following:
1.34.1 Antibody expression constructs;
1.34.2 methods of transfecting cells and selecting transfected cells;
1.34.3 cell culture media;
1.34.4 cell culture conditions; and/or
1.34.5 other methods and compositions for enhancing the expression and recovery of recombinant proteins from cultured cells.
For the purposes of clarification, Licensee Improvements includes vectors developed by Licensee without use of Licensor Vectors, including transients, stable pools and clonal manufacturing cell lines, but shall not include any Licensor Improvements.
1.35 Licensee Technology means Antibodies and Products and related Know-How and Patents, but does not include Licensor Technology, including but not limited to methods for the selection of transfected Potelligent® CHOK1SV cells.
1.36 Licensor Improvements means Improvements derived from use of the Potelligent® [***] cells or Potelligent® [***] cell-related Know-How that relate specifically to Licensor Technology (other than inventions that relate specifically to Licensee Technology)
[*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.